scholarly journals Donor-Specific Anti-HLA Antibodies in Organ Transplantation: Transition from Serum DSA to Intra-Graft DSA

Author(s):  
Tsukasa Nakamura ◽  
Hidetaka Ushigome ◽  
Takayuki Shirouzu ◽  
Norio Yoshimura
2017 ◽  
Vol 78 ◽  
pp. 97 ◽  
Author(s):  
Peter Jindra ◽  
Thuydung Tu ◽  
Holly Dane ◽  
Lauren E. Clark ◽  
Anna-Marie Young ◽  
...  

2012 ◽  
Vol 17 (4) ◽  
pp. 440-445 ◽  
Author(s):  
Duska Dragun ◽  
Aurélie Philippe ◽  
Rusan Catar

2016 ◽  
Vol 77 (11) ◽  
pp. 1055-1062 ◽  
Author(s):  
Marianne Delville ◽  
Béatrice Charreau ◽  
Marion Rabant ◽  
Christophe Legendre ◽  
Dany Anglicheau

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Annette M. Jackson ◽  
Chris Wiebe ◽  
Michelle J. Hickey

2013 ◽  
Vol 18 (4) ◽  
pp. 430-435 ◽  
Author(s):  
Duska Dragun ◽  
Rusan Catar ◽  
Aurélie Philippe

2020 ◽  
Vol 1 (1) ◽  
pp. 24-41
Author(s):  
María Gutiérrez-Larrañaga ◽  
Marcos López-Hoyos ◽  
André Renaldo ◽  
David San Segundo

The role of anti-HLA antibodies in solid organ rejection is well established and these antibodies are routinely monitored both in patients in the waiting list and in the post-transplant setting. More recently, the presence of other antibodies directed towards non-HLA antigens, or the so-called minor histocompatibility antigens, has drawn the attention of the transplant community; however, their possible involvement in the graft outcome remains uncertain. These antibodies have been described to possibly have a role in rejection and allograft failure. This review focuses on the most studied non-HLA antibodies and their association with different clinical outcomes considered in solid organ transplantation with the aim of clarifying their clinical implication and potential relevance for routine testing.


Sign in / Sign up

Export Citation Format

Share Document